Increased Polysedative Use in Veterans with Posttraumatic Stress Disorder

Pain Medicine (United States)

Volumn 15, Issue 7, 2014, Pages 1083-1090

  Bernardy, Nancy C ^a,b   Lund, Brian C ^c   Alexander, Bruce ^c   Friedman, Matthew J ^a,b  

^a NATIONAL CENTER FOR PTSD   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical pharmacology; Coordinated care; Posttraumatic stress disorder

Indexed keywords

ANALGESIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BACLOFEN; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CARISOPRODOL; CHLORZOXAZONE; CYCLOBENZAPRINE; DANTROLENE; ESZOPICLONE; HYPNOTIC AGENT; METAXALONE; METHOCARBAMOL; MUSCLE RELAXANT AGENT; OPIATE; ORPHENADRINE; RAMELTEON; SEDATIVE AGENT; TIZANIDINE; ZOLPIDEM; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; ARTICLE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PREVALENCE; RACE DIFFERENCE; RURAL POPULATION; SEX DIFFERENCE; URBAN POPULATION; VETERAN; MIDDLE AGED; POLYPHARMACY; STATISTICS AND NUMERICAL DATA; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES;

ADULT; AGED; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; POLYPHARMACY; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; VETERANS;

EID: 84904791444     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12321     Document Type: Article

References (31)

1. Haskell SG, Brandt CA, Krebs EE, etal. Pain among Veterans of Operations Enduring Freedom and Iraqi Freedom: Do women and men differ? Pain Med 2009;10(7):1167-1173.
2. Beckham JC, Crawford AL, Feldman ME, etal. Chronic posttraumatic stress disorder and chronic pain in Vietnam combat veterans. J Psychosom Res 1997;43(4):379-389.
3. Lew HL, Otis JD, Tun C, etal. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: Polytrauma clinical triad. J Rehabil Res Dev 2009;46(6):697-702.
4. Shipherd JC, Keyes M, Jovanovic T, etal. Veterans seeking treatment for posttraumatic stress disorder: What about comorbid chronic pain? J Rehabil Res Dev 2007;44(2):153-166.
5. Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder: Epidemiology, impact and approaches to management. CNS Drugs 2006;20(7):567-590.
6. Gibson CA. Review of posttraumatic stress disorder and chronic pain: The path to integrated care. J Rehabil Res Dev 2012;49(5):753-776.
7. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(6):617-627.
8. Alexander GC, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA 2012;308(18):1865-1866.
9. Department of Veterans Affairs. Post traumatic stress disorder: VA/DoD Clinical Practice Guideline; 2010. Available at: http://www.healthquality.va.gov/Post_Traumatic_Stress_Disorder_PTSD.asp [accessed October 2010] October 31, 2013.
10. Department of Veterans Affairs. Management of opioid therapy for chronic pain: VA/DoD Clinical Practice Guideline; 2010. Available at: http://www.healthquality.va.gov/COT_312_Full-er.pdf [accessed May 2010] October 31, 2013.
11. Substance Abuse and Mental Health Service Administration. Pharmacologic guidelines for treating individuals with post-traumatic stress disorder and co-occurring opioid use disorders. Rockville, MD: Substance abuse and mental health service administration; 2012. Available from: http://www.samhsa.gov/co-occurring/docs/Pharm_Guidelines_508.pdf [updated May 2012] October, 31, 2013.
12. Bernardy NC, Lund BC, Alexander B, etal. Gender differences in prescribing among veterans diagnosed with posttraumatic stress disorder. J Gen Intern Med 2013;28(suppl 2):S542-548.
13. Lund BC, Bernardy NC, Vaughan-Sarrazin M, Alexander B, Friedman MJ. Patient and facility characteristics associated with benzodiazepine prescribing for veterans with PTSD. Psychiatr Serv 2013;64(2):149-155.
14. Harpaz-Rotem I, Rosenheck RA. Tracing the flow of knowledge: Geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs. Arch Gen Psychiatry 2009;66(4):417-421.
15. Lund BC, Bernardy NC, Alexander BA, Friedman MJ. Declining benzodiazepine use in veterans with posttraumatic stress disorder. J Clin Psychiatry 2012;73(3):292-296. 0160-6689.
16. Abrams TE, Lund BC, Bernardy NC, Friedman MJ. Aligning clinical practice to PTSD treatment guidelines: Medication prescribing by provider type. Psychiatr Serv 2013;64(2):142-148.
17. Bernardy NC, Lund BC, Alexander BA, Friedman MJ. Prescribing trends in veterans with posttraumatic stress disorder. J Clin Psychiatry 2012;73(3):297-303.
18. Mohamed S, Rosenheck RA. Pharmacotherapy for older veterans diagnosed with posttraumatic stress disorder in Veterans Administration. Am J Geriatr Psychiatry 2008;16(10):804-812.
19. Lund BC, Abrams TE, Bernardy NC, Alexander B, Friedman MJ. Benzodiazepine prescribing variation and clinical uncertainty in treating posttraumatic stress disorder. Psychiatr Serv 2013;64(1):21-27.
20. Gravely AA, Cutting A, Nugent S, etal. Validity of PTSD diagnoses in VA administrative data: Comparison of VA administrative PTSD diagnoses to self-reported PTSD checklist scores. J Rehabil Res Dev 2011;48(1):21-30.
21. Lund BC, Abrams TE, Gravely AA. Rebuttal to Gravely etal., "Validity of PTSD diagnoses in VA administrative data: Comparison of VA administrative PTSD diagnoses to self-reported PTSD checklist scores" [letter]. J Rehabil Res Dev 2011;48(5):vii-ix.
22. Ernst M, Lund BC. Renewed interest in chlorthalidone: Evidence from the Veterans Health Administration. J Clin Hypertens 2010;12:927-934.
23. Seal KH, Shi Y, Cohen G, etal. Association of mental health disorders with prescription opioids and high-risk opioid use in US Veterans of Iraq and Afghanistan. JAMA 2012;307(9):940-947.
24. Hawkins EJ, Malte CA, Imel ZE, Saxon AJ, Kivlahan DR. Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-3010. Drug Alcohol Depend 2012;124(1-2):154-161.
25. Krystal JH, Rosenheck RA, Cramer JA, etal. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: A randomized trial. JAMA 2011;306(5):493-502.
26. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: A review of the evidence. Clin J Pain 2008;24(6):469-478. 0749-8047.
27. Gallagher PJ, Castro V, Fava M, etal. Antidepressant response in patients with major depression exposed to NSAIDs: A pharmacovigilance study. Am J Psychiatry 2012;169(10):1065-1072.
28. Keneally R, Spevak C, Shields C. Mitigating prescription medication misuse in U.S. service members. Fed Pract 2012;9S-12S.
29. Peppin JF, Kirsh KL. A sampling of potential adverse effects with chronic opioid therapy. Fed Pract 2012;13S-23S.
30. Dunn KM, Saunders KW, Rutter CM, etal. Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 2010;152(2):85-92.
31. McLellan AT, Turner BJ. Chronic noncancer pain management and opioid overdose: Time to change prescribing practices. Ann Intern Med 2010;152(2):123-124.